AzTrials
AzTrials

Over WeightPhase 2/3NCT01358890

Low-Carbohydrate Diet Intervention on Body Weight

A Phase 2/3 study testing low carbohydrate diet and Calories restricted diet in people with Over Weight and Obesity, run by Chinese Academy of Sciences at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary aim of this study is to determine the adherence of low- carbohydrate among Chinese. Then compare the effect of low-carbohydrate and traditional Chinese but restricted-calories diet on weight loss and metabolic traits. Read more about this study

Who is it for?
Ages 30 to 65 years
Conditions the study is for
Over Weight, Obesity
What is being tested?
low carbohydrate diet and Calories restricted diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteChina
Study dates
May 2011to Aug 2011
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • overweight/obese (BMI ≥24 kg/m2)

Who cannot join

  • Pregnancy or lactation;
  • Serum creatinine and blood urea nitrogen level beyond the clinical reference value;
  • alanine aminotransferase and aspartate aminotransferase beyond the reference levels;
  • Gastrointestinal problems that would prevent them from complying with the specified feeding conditions;
  • Received gastrointestinal surgery (except for appendicitis or hernia);
  • Severer CVD;
Show all 9Show fewer
  • Active cancer;
  • Mental diseases, epilepsia or using anti-depression drugs;
  • Participating in other scientific studies within 3 months before the study.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Institute for Nutritional Sciences, Chinese Academy of Sciences

    Shanghai, Shanghai Municipality, 200031

Other trials in China

About this study

Official title: Effect of Low-Carbohydrate or Restricted-Calories Diet on Body Weight

  • The primary aim of this study is to determine the adherence of low- carbohydrate among Chinese.
  • Then compare the effect of low-carbohydrate and traditional Chinese but restricted-calories diet on weight loss and metabolic traits.
Read the detailed description

Obesity is a well established risk factor for type 2 diabetes mellitus, hypertension, dyslipidemia and cardiovascular disease. Along with rapid nutritional and lifestyle transition featured as increased energy dense diet intake and reduced physical activity, the prevalence of obesity has reached epidemic level and affected more than 70 million Chinese adults nowadays. Previous studies suggested that low-carbohydrate diet was an effective and safe way to lose weight and had potential benefit on lipids profiles. However, it is still unknown whether this diet can be feasible to control the epidemic of obesity and its related metabolic diseases among Chinese, whose carbohydrate consumption contribute approximately 55% of total energy intake.

Therefore, the aim of this pilot study is to investigate the adherence and effectiveness of two weight-loss diets among Chinese. This will be a randomized, controlled clinical trial. A total of 50 overweight or obese nurse assistants will be randomly assigned to receive a low-carbohydrate diet or a traditional high-carbohydrate Chinese but restricted-calories diet for 12 weeks. The adherence of study protocol and effects of the two diets on body weight, waist circumference, body fat, fasting glucose and lipid profile will be evaluated.

Conditions
Over Weight, Obesity
Being tested
low carbohydrate diet, Calories restricted diet
Keywords
over weight, obesity
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • low carbohydrate dietOther

    Dietary carbohydrate diet was restricted to 20 gram/day within the first week, then increase gradually to 120 gram/day

  • Calories restricted dietOther

    Total energy intake is restricted to 1200 kcal/day for women. Energy from carbohydrate, protein and fat will be kept to approximate 55%, 20% and 25%, respectively. Moreover, saturated fat and dietary cholesterol are restricted to at most 10% energy and 300 mg/day, respectively

Study groups in NCT01358890
Study groupRoleWhat they receive
BExperimentalSubjects will be supplied with low carbohydrate diet for 12 weeks.
Receives: Other: low carbohydrate diet
AExperimentalSubjects will be supplied with calories restricted diet for 12 weeks
Receives: Other: Calories restricted diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. weight

    Measured: 12 weeks

Secondary outcomes (10)
  1. body fat mass

    Measured: 12 weeks

  2. waist circumference

    Measured: 12 weeks

  3. body mass index

    Measured: 12 weeks

  4. fast glucose

    Measured: 12 weeks

  5. total cholesterol

    Measured: 12 weeks

  6. triglyceride

    Measured: 12 weeks

  7. LDL-C

    Measured: 12 weeks

  8. HDL-C

    Measured: 12 weeks

  9. blood pressure

    Measured: 12 weeks

  10. urinary ketone

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2011 (estimated)
  2. Study startMay 2011
  3. Primary completionAug 2011
  4. Study completionAug 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01358890
Sponsor's protocol ID
30930081/C150502-LC
Status last verified
Feb 2012
First submitted
23 May 2011
Last updated
28 Feb 2012
Results posted
No

Publications

  • Ma Y, Sun Y, Sun L, Liu X, Zeng R, Lin X, Li Y. Effects of gut microbiota and fatty acid metabolism on dyslipidemia following weight-loss diets in women: Results from a randomized controlled trial. Clin Nutr. 2021 Nov;40(11):5511-5520. doi: 10.1016/j.clnu.2021.09.021. Epub 2021 Sep 23.

    PubMed 34656033

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing low carbohydrate diet and Calories restricted diet in people with Over Weight and Obesity, run by Chinese Academy of Sciences at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Feb 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

weight (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01358890, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2012; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in